期刊文献+

成人斑秃与甲状腺自身免疫的关系分析 被引量:5

Association analysis between alopecia areata and thyroid autoimmunity in adults
原文传递
导出
摘要 目的评估成人斑秃患者甲状腺功能异常及甲状腺自身抗体的发生率,分析成人斑秃与甲状腺自身免疫的关系。方法按照预先设计的调查表收集斑秃患者人口学信息、病史、斑秃一级亲属家族史,并检测甲状腺功能和甲状腺过氧化物酶抗体(TPO—Ab)。结果共有209例患者入选,6.7%的患者伴发甲状腺疾病,20.6%的患者TPO—Ab阳性。与TPO—Ab阴性的患者比较,TPO—Ab阳性的患者斑秃首次发病年龄〈18岁(P=0.025)、发生全秃和(或)普秃(AT/AU)的概率更大(P=0.006)、合并甲状腺疾病的概率更大(P=0.002)、有更多的一级直系亲属成员患有斑秃(P=0.001)。结论斑秃患者TPO—Ab阳性率较高,即使无甲状腺受累的临床表现,也需对斑秃患者进行甲状腺功能及甲状腺自身抗体检测。 Objective To estimate the prevalence of thyroid dysfunction and thyroid autoantibodies in adults with alopeeia areata (AA), and to analyze the relationship between alopecia areata (AA) and thyroid autoimmunity in adults. Methods A predesigned questionnaire was used to collect data on demographic information, medical history, and family history of AA in first-degree relatives from patients with AA. Thyroid function was evaluated, and anti-thyroid peroxidase antibody (TPO-Ab) was screened in all the patients. Statistical analysis was carried out by the chi-square test and Fisher's exact test. Results Totally, 209 patients with AA were enrolled. Of these patients, 6.7% were complicated by thyroid diseases, 20.6% were positive for TPO-Ab. Compared with the patients without TPO-Ab, those with TPO-Ab showed a significant increase in the proportion of patients with early-onset (〈 18 years) AA (χ^2 = 5.589, P = 0.025 ), prevalenee rate of alopecia totalis/alopecia universalis (χ^2 = 9.990, P= 0.006) and thyroid diseases (χ^2 = 12.279, P= 0.002), and incidence rate of AA in first-degree relatives (χ^2 = 14.426, P = 0.001 ). Conclusions The positive rate of TPO-Ab is increased in patients with AA. It is recommended to evaluate thyroid function and to screen for thyroid autoantibodies in patients with AA despite of the absence of clinical manifestations of thyroid diseases.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2015年第10期697-699,共3页 Chinese Journal of Dermatology
关键词 斑秃 甲状腺 甲状腺炎 自身免疫性 甲状腺功能减退症 成年人 Alopeeia areata Thyroid gland Thyroiditis, autoimmune Hypothyroidism Adult
  • 相关文献

参考文献15

  • 1Hordinsky MK. Overview of alopecia areata[ J ]. J Investig Dermatol Symp Proc, 2013, 16( 1 ): S13-S15.
  • 2Huang KP, Mullangi S, Guo Y, et al. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States [ J ]. JAMA Dermatol, 2013, 149(7 ): 789-794.
  • 3Chu SY, Chert YJ, Tseng WC, et al. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study [ J ]. J Am Acad Dermatol, 2011, 65(5): 949-956.
  • 4曾敬思,曾昭明.斑秃与白癜风及甲状腺疾病并发的分析[J].中华皮肤科杂志,1999,32(1):54.
  • 5Olsen EA. Investigative guidelines for alopecia areata [ J ]. Dermatol Ther, 2011, 24(3): 311-319.
  • 6Islam N, Leung PS, Huntley AC, et al. The autoimmune basis of alopecia areata: a comprehensive review [J]. Autoimmun Rev, 2015, 14(2): 81-89.
  • 7杨竹生,林麟.自身反应性T细胞与斑秃[J].国际皮肤性病学杂志,2006,32(6):362-364. 被引量:7
  • 8Kakourou T, Karachristou K, Chrousos G. A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity [J]. J Eur Acad Dermatol Venereol, 2007, 21 (3): 356-359.
  • 9Thomas EA, Kadyan RS. Alopeeia areata and autoimmunity: a clinical study[ J ]. Indian J Dermatol, 2008, 53 (2): 70-74.
  • 10Baars MP, Greebe RJ, Pop VJ. High prevalence of thyroid peroxidase antibodies in patients with alopecia areata [J]. J Eur Acad Dermatol Venereol, 2013, 27( 1 ): e137-139.

二级参考文献23

  • 1Alexis AF,Dudda-Subramanya R,Sinha AA.Alopecia areata:autoimmune basis of hair loss.Eur J Dermatol,2004,14:364-370.
  • 2Chow S,Rizzo C,Ravitskiy L,et al.The role of T cells in cutaneous autoimmune disease.Autoimmunity,2005,38:303-317.
  • 3McElwee KJ,Hoffmann R,Freyschmidt-Paul P,et al.Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells.J Invest Dermatol,2002,119:1426-1433.
  • 4McElwee KJ,Freyschmidt-Paul P,Hoffmann R,et al.Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-)cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model.J Invest Dermatol,2005,124:947-957.
  • 5Zoller M,McElwee KJ,Vitacolonna M,et al.Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients.J Autoimmun,2004,23:241-256.
  • 6Carroll JM,McElwee KJ,E King L,et al.Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.J Invest Dermatol,2002,119:392-402.
  • 7Zoller M,McElwee KJ,Engel P,et al.Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata.J Invest Dermatol,2002,118:983-992.
  • 8Yano S,Nakamura K,Okochi H,et al.Analysis of the expression of cutaneous lymphocyte-associated antigen on the peripheral blood and cutaneous lymphocytes of alopecia areata patients.Acta Derm Venereol,2002,82:82-85.
  • 9Lacueva L,Guilabert A,Ferrando J.The expression of cutaneous lymphocyte-associated antigen (CLA) in alopecia areata.Eur J Dermatol,2005,15:201-202.
  • 10Wagner SN,Wagner C,Reinhold U,et al.Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.J Invest Dermatol,1998,111:464-471.

共引文献6

同被引文献31

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部